Risk stratification of solitary hepatocellular carcinoma ≤ 5 cm without microvascular invasion: prognostic values of MR imaging features based on LI-RADS and clinical parameters

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2018)Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases Hepatology 68 723-750

[3] Siegel RL(2016)Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria JAMA Surg 151 356-363

[4] Marrero JA(2016)Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update World J Gastroenterol 22 9279-9287

[5] Kulik LM(2022)Predicting microvascular invasion in hepatocellular carcinoma: a dual-institution study on gadoxetate disodium-enhanced MRI Liver Int 42 1158-1172

[6] Sirlin CB(2021)Development and validation of a model including distinct vascular patterns to estimate survival in hepatocellular carcinoma JAMA Netw Open 4 3845-3854

[7] Lei Z(2022)Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi-institutional analysis Ann Surg Oncol 46 278-354

[8] Li J(2021)Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection Abdom Radiol (NY) 18 344-443

[9] Wu D(2018)The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis BMC Cancer 49 433-1173

[10] Cong WM(2019)Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis Hepatol Res 276 1164-548

[1] Sung H(2021)Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 71 209-249

[2] Ferlay J(2018)Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases Hepatology 68 723-750

[3] Siegel RL(2016)Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria JAMA Surg 151 356-363

[4] Marrero JA(2016)Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update World J Gastroenterol 22 9279-9287

[5] Kulik LM(2022)Predicting microvascular invasion in hepatocellular carcinoma: a dual-institution study on gadoxetate disodium-enhanced MRI Liver Int 42 1158-1172

[6] Sirlin CB(2021)Development and validation of a model including distinct vascular patterns to estimate survival in hepatocellular carcinoma JAMA Netw Open 4 3845-3854

[7] Lei Z(2022)Clinical features of recurrence after hepatic resection for early-stage hepatocellular carcinoma and long-term survival outcomes of patients with recurrence: a multi-institutional analysis Ann Surg Oncol 46 278-354

[8] Li J(2021)Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection Abdom Radiol (NY) 18 344-443

[9] Wu D(2018)The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis BMC Cancer 49 433-1173

[10] Cong WM(2019)Microvascular invasion predicts a poor prognosis of solitary hepatocellular carcinoma up to 2 cm based on propensity score matching analysis Hepatol Res 276 1164-548